Stock Taper
Latest 13F filing data - Q2 2023
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Medtronic plc | MDT | 344.42K | $30.34M |
Guardant Health, Inc. | GH | 346.08K | $12.39M |
uniQure N.V. | QURE | 356.28K | $4.08M |
Diversified Healthcare Trust | DHC | 357.72K | $804.87K |
| AS Assertio Holdings, Inc. | ASRT | 410.57K | $2.23M |
Adaptive Biotechnologies Corporation | ADPT | 422.28K | $2.83M |
Bristol-Myers Squibb Company | BMY | 458.5K | $29.32M |
Avantor, Inc. | AVTR | 459.49K | $9.44M |
Teva Pharmaceutical Industries Limited | TEVA | 459.65K | $3.46M |
BioCryst Pharmaceuticals, Inc. | BCRX | 504.53K | $3.55M |
Sabra Health Care REIT, Inc. | SBRA | 510.66K | $6.01M |
Ardelyx, Inc. | ARDX | 539.41K | $1.83M |
AbbVie Inc. | ABBV | 545.63K | $73.51M |
Abbott Laboratories | ABT | 552.46K | $60.23M |
Caribou Biosciences, Inc. | CRBU | 567.15K | $2.41M |
Amgen Inc. | AMGN | 616.54K | $136.88M |
Boston Scientific Corporation | BSX | 657.79K | $35.58M |
Pyxis Oncology, Inc. | PYXS | 708.3K | $1.81M |
Johnson & Johnson | JNJ | 721.78K | $119.47M |
Exelixis, Inc. | EXEL | 726.64K | $13.89M |